Nang Kuang Pharmaceutical Co., Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was TWD 573.08 million compared to TWD 375.75 million a year ago. Net income was TWD 93.97 million compared to TWD 41.02 million a year ago.

Basic earnings per share from continuing operations was TWD 0.93 compared to TWD 0.41 a year ago. Diluted earnings per share from continuing operations was TWD 0.93 compared to TWD 0.41 a year ago.